Jayson Bedford
Stock Analyst at Raymond James
(4.65)
# 819
Out of 4,429 analysts
724
Total ratings
59.4%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Jayson Bedford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $81 → $91 | $72.47 | +25.57% | 75 | Jun 8, 2026 | |
| PODD Insulet | Maintained: Buy | $263 → $216 | $145.76 | +48.19% | 46 | Jun 8, 2026 | |
| TFX Teleflex | Maintained: Buy | $128 → $150 | $127.00 | +18.11% | 13 | May 8, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $102 → $83 | $67.22 | +23.48% | 45 | May 1, 2026 | |
| AXGN Axogen | Maintained: Buy | $41 → $48 | $44.84 | +7.05% | 8 | Apr 29, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $124 → $88 | $45.29 | +94.30% | 76 | Mar 27, 2026 | |
| SYK Stryker | Upgraded: Buy | $418 | $307.80 | +35.80% | 4 | Jan 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Downgraded: Hold | n/a | $87.97 | - | 9 | Jan 6, 2026 | |
| EW Edwards Lifesciences | Upgraded: Buy | $96 | $87.36 | +9.89% | 30 | Nov 3, 2025 | |
| ISRG Intuitive Surgical | Maintained: Buy | $592 → $603 | $406.78 | +48.24% | 15 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $18.03 | +5.38% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $141 → $146 | $88.41 | +65.14% | 84 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $164 → $209 | $228.39 | -8.49% | 68 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $79.34 | - | 29 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $180 | $140.37 | +28.23% | 59 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $6.74 | - | 26 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $19.89 | - | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.58 | - | 29 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $143.98 | n/a | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.89 | n/a | 16 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $15.30 | n/a | 17 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $13 | $12.15 | n/a | 41 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 12 | Jul 23, 2019 |
DexCom
Jun 8, 2026
Maintained: Buy
Price Target: $81 → $91
Current: $72.47
Upside: +25.57%
Insulet
Jun 8, 2026
Maintained: Buy
Price Target: $263 → $216
Current: $145.76
Upside: +48.19%
Teleflex
May 8, 2026
Maintained: Buy
Price Target: $128 → $150
Current: $127.00
Upside: +18.11%
Merit Medical Systems
May 1, 2026
Maintained: Buy
Price Target: $102 → $83
Current: $67.22
Upside: +23.48%
Axogen
Apr 29, 2026
Maintained: Buy
Price Target: $41 → $48
Current: $44.84
Upside: +7.05%
Boston Scientific
Mar 27, 2026
Maintained: Buy
Price Target: $124 → $88
Current: $45.29
Upside: +94.30%
Stryker
Jan 6, 2026
Upgraded: Buy
Price Target: $418
Current: $307.80
Upside: +35.80%
Zimmer Biomet Holdings
Jan 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $87.97
Upside: -
Edwards Lifesciences
Nov 3, 2025
Upgraded: Buy
Price Target: $96
Current: $87.36
Upside: +9.89%
Intuitive Surgical
Oct 22, 2025
Maintained: Buy
Price Target: $592 → $603
Current: $406.78
Upside: +48.24%
Oct 20, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $18.03
Upside: +5.38%
Oct 16, 2025
Maintained: Buy
Price Target: $141 → $146
Current: $88.41
Upside: +65.14%
Oct 15, 2025
Maintained: Buy
Price Target: $164 → $209
Current: $228.39
Upside: -8.49%
Aug 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $79.34
Upside: -
Aug 8, 2025
Maintained: Buy
Price Target: $187 → $180
Current: $140.37
Upside: +28.23%
Aug 8, 2025
Reiterated: Sell
Price Target: n/a
Current: $6.74
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $19.89
Upside: -
Aug 1, 2025
Maintained: Hold
Price Target: n/a
Current: $17.58
Upside: -
May 2, 2025
Downgraded: Hold
Price Target: n/a
Current: $143.98
Upside: n/a
Nov 16, 2023
Downgraded: Hold
Price Target: n/a
Current: $14.89
Upside: n/a
May 4, 2023
Maintained: Hold
Price Target: n/a
Current: $15.30
Upside: n/a
Apr 17, 2023
Maintained: Buy
Price Target: $14 → $13
Current: $12.15
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a